- Patent Title: Anti-CD47 x anti-mesothelin antibodies and methods of use thereof
-
Application No.: US15991774Application Date: 2018-05-29
-
Publication No.: US11260117B2Publication Date: 2022-03-01
- Inventor: Krzysztof Masternak , Nicolas Fischer
- Applicant: NovImmune SA
- Applicant Address: CH Geneva
- Assignee: NovImmune SA
- Current Assignee: NovImmune SA
- Current Assignee Address: CH Geneva
- Agency: Cooley LLP
- Agent Cynthia A. Kozakiewicz; Ivor R. Elrifi
- Main IPC: C07K16/00
- IPC: C07K16/00 ; A61K39/00 ; C07K16/28 ; C07K16/30 ; A61K39/395 ; C07K16/46 ; A61P35/00
Abstract:
The invention also relates to novel bispecific antibodies carrying a different specificity for each binding site of the immunoglobulin molecule, where one of the binding sites is specific for CD47 and the second is specific for mesothelin (MSLN).
Public/Granted literature
- US20180339031A1 ANTI-CD47 X ANTI-MESOTHELIN ANTIBODIES AND METHODS OF USE THEREOF Public/Granted day:2018-11-29
Information query
